Basel Medical Group Ltd Ordinary Shares (BMGL) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -302.73K |
| Operating CF Growth % | - |
| Operating CF / Revenue % | -5% |
| Net Income | -9.94M |
| Depreciation & Amortization | 799.14K |
| Stock-Based Compensation | 0 |
| Deferred Taxes | 0 |
| Other Non-Cash Items | 10.18M |
| Working Capital Changes | -1.34M |
| Cash from Investing | -10.48M |
| Capital Expenditures | -518.8K |
| Acquisitions | -9.96M |
| Purchase of Investments | 0 |
| Sale/Maturity of Investments | 0 |
| Other Investing | 0 |
| Cash from Financing | 6.98M |
| Dividends Paid | 0 |
| Share Repurchases | 0 |
| Stock Issued | 9.39M |
| Debt Issuance (Net) | -1000K |
| Other Financing | 649.21K |
| Net Change in Cash | -3.91M |
| Exchange Rate Effect | -115.93K |
| Cash at Beginning | 6.96M |
| Cash at End | 3.05M |
| Free Cash Flow | -821.53K |
| FCF Growth % | - |
| FCF Margin % | -13.57% |
| FCF per Share | -0.04 |